Investigation of Colistin resistance and method comparison in Klebsiella pneumoniae strains

Diagn Microbiol Infect Dis. 2025 Jan;111(1):116584. doi: 10.1016/j.diagmicrobio.2024.116584. Epub 2024 Oct 29.

Abstract

Purpose: This study aimed to assess the prevalence of colistin resistance in the study group and compare alternative methods with the gold standard. It sought to evaluate the prevalence of plasmid-mediated colistin resistance genes.

Material and methods: The colistin susceptibility of 151 K. pneumoniae strains was determined using Sensititre™, CBDE, ETEST®, and VITEK®2. Results were compared with BMD. The presence of the mcr gene was assessed using polymerase chain reaction.

Results: The colistin resistance rate was 16,6 %. The categorical agreement of Sensititre™, CBDE, and ETEST® was 100 %. VITEK®2 had a CA of 98 %, a major error of 0.79 %, and a very major error of 8 %. Essential agreement for Sensititre™, ETEST®, and VITEK®2 was 92.7 %, 52.3 %, and 78.1 %, respectively. There were no mcr genes in any strains.

Conclusions: Due to the difficulty of applying BMD, colistin resistance data are insufficient globally. Continuous epidemiological studies and validation of alternative methods are needed.

Keywords: Antimicrobial resistance; Colistin; Klebsiella pneumoniae; Polymerase chain reaction.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Colistin* / pharmacology
  • Drug Resistance, Bacterial* / genetics
  • Humans
  • Klebsiella Infections / epidemiology
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae* / drug effects
  • Klebsiella pneumoniae* / genetics
  • Microbial Sensitivity Tests*
  • Plasmids / genetics
  • Polymerase Chain Reaction

Substances

  • Colistin
  • Anti-Bacterial Agents